https://www.businesswire.com/news/home/20260406785300/en/Nexus-Pharmaceuticals-Launches-Cyclophosphamide-Injection-2.5-mL-and-5-mL
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL
cyclophosphamide injection2 5nexuspharmaceuticalslaunches
https://www.medicines.org.uk/emc/product/1814/smpc/print
Cyclophosphamide Injection 1 g - Summary of Product Characteristics (SmPC) - print friendly - (emc)
Cyclophosphamide Injection 1 g - Summary of Product Characteristics (SmPC) by Baxter Healthcare Ltd - print friendly
cyclophosphamide injection1 g
https://www.medicines.org.uk/emc/product/100935/smpc
Cyclophosphamide Seacross 1000 mg powder for solution for injection/infusion - Summary of Product...
Cyclophosphamide Seacross 1000 mg powder for solution for injection/infusion - Summary of Product Characteristics (SmPC) by Seacross Pharmaceuticals Ltd
1000 mg
https://www.medicines.org.uk/emc/product/3524/smpc
Cyclophosphamide 2000 mg Powder for Solution for Injection or Infusion - Summary of Product...
Cyclophosphamide 2000 mg Powder for Solution for Injection or Infusion - Summary of Product Characteristics (SmPC) by Sandoz Limited
2000 mg
https://www.biospace.com/fresenius-kabi-further-expands-oncology-portfolio-with-launch-of-cyclophosphamide-for-injection-usp
Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection,...
Feb 28, 2024 - Fresenius Kabi announced today it has introduced Cyclophosphamide for Injection, USP, a generic substitute for Cytoxan, for use in treating several forms of...
fresenius kabioncology portfolio